Yukitoshi Satoh

7.8k total citations · 2 hit papers
187 papers, 5.9k citations indexed

About

Yukitoshi Satoh is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Yukitoshi Satoh has authored 187 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 112 papers in Pulmonary and Respiratory Medicine, 68 papers in Oncology and 39 papers in Molecular Biology. Recurrent topics in Yukitoshi Satoh's work include Lung Cancer Treatments and Mutations (62 papers), Lung Cancer Diagnosis and Treatment (54 papers) and Lung Cancer Research Studies (29 papers). Yukitoshi Satoh is often cited by papers focused on Lung Cancer Treatments and Mutations (62 papers), Lung Cancer Diagnosis and Treatment (54 papers) and Lung Cancer Research Studies (29 papers). Yukitoshi Satoh collaborates with scholars based in Japan, India and United States. Yukitoshi Satoh's co-authors include Ken Nakagawa, Yuichi Ishikawa, Sakae Okumura, Yuki Togashi, Kengo Takeuchi, Manabu Soda, Young Lim Choi, Hiroyuki Mano, Kentaro Inamura and Satoko Hatano and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Yukitoshi Satoh

169 papers receiving 5.7k citations

Hit Papers

RET, ROS1 and ALK fusions in lung cancer 2009 2026 2014 2020 2012 2009 250 500 750

Peers

Yukitoshi Satoh
Yukitoshi Satoh
Citations per year, relative to Yukitoshi Satoh Yukitoshi Satoh (= 1×) peers Koh Furuta

Countries citing papers authored by Yukitoshi Satoh

Since Specialization
Citations

This map shows the geographic impact of Yukitoshi Satoh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yukitoshi Satoh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yukitoshi Satoh more than expected).

Fields of papers citing papers by Yukitoshi Satoh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yukitoshi Satoh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yukitoshi Satoh. The network helps show where Yukitoshi Satoh may publish in the future.

Co-authorship network of co-authors of Yukitoshi Satoh

This figure shows the co-authorship network connecting the top 25 collaborators of Yukitoshi Satoh. A scholar is included among the top collaborators of Yukitoshi Satoh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yukitoshi Satoh. Yukitoshi Satoh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Naito, Masahito, et al.. (2025). Characteristics of Oligo-Recurrence and Treatment Selection in Non-Small Cell Lung Cancer. Cancers. 17(14). 2293–2293.
2.
Naito, Masahito, et al.. (2024). Prognostic factors after radical local therapy for oligo-recurrence of non-small cell lung cancer. General Thoracic and Cardiovascular Surgery. 73(5). 352–361. 2 indexed citations
3.
Mikubo, Masashi, Masaaki Ichinoe, Masahito Naito, et al.. (2024). Radiologic Parameters Predicting the Histologic Invasiveness of Pure Ground-Glass Nodules. SHILAP Revista de lepidopterología. 2(3). 464–468.
4.
Canberk, Şule, Andrew Field, Lukas Bubendorf, et al.. (2023). A brief review of the WHO reporting system for lung cytopathology. Journal of the American Society of Cytopathology. 12(4). 251–257. 12 indexed citations
5.
Mikubo, Masashi, Yukitoshi Satoh, Masahito Naito, et al.. (2023). Prognostic implications of prostaglandin E-major urinary metabolite in resected non-small-cell lung cancer. Interdisciplinary CardioVascular and Thoracic Surgery. 36(1). 1 indexed citations
6.
Yoshizawa, Akihiko, Kenzo Hiroshima, Akemi Takenaka, et al.. (2021). Cytology Reporting System for Lung Cancer from the Japan Lung Cancer Society and the Japanese Society of Clinical Cytology: An Extensive Study Containing More Benign Lesions. Acta Cytologica. 66(2). 124–133. 10 indexed citations
7.
Naito, Masahito, et al.. (2021). Selection of preoperative stress electrocardiography test for appropriate patients with non-small cell lung cancer. General Thoracic and Cardiovascular Surgery. 70(2). 139–143. 1 indexed citations
9.
Matsuura, Yosuke, Junji Ichinose, Masayuki Nakao, et al.. (2019). <p>Ultra-late recurrence of non-small cell lung cancer over 10 years after curative resection</p>. Cancer Management and Research. Volume 11. 6765–6774. 18 indexed citations
10.
Mikubo, Masashi, et al.. (2019). Ciliated muconodular papillary tumors of the lung: Cytologic features and diagnostic pitfalls in intraoperative examinations. Diagnostic Cytopathology. 47(7). 716–719. 11 indexed citations
11.
Matsui, Yoshio, et al.. (2019). Resection of intra-pulmonary endometriosis by video-assisted thoracoscopic surgery under pre-operative CT-guided marking synchronized with menstrual cycle. General Thoracic and Cardiovascular Surgery. 68(5). 549–553. 4 indexed citations
12.
Matsuo, Yukiko, Tsutomu Yoshida, Kazuya Yamashita, & Yukitoshi Satoh. (2018). Reducing DNA damage by formaldehyde in liquid‐based cytology preservation solutions to enable the molecular testing of lung cancer specimens. Cancer Cytopathology. 126(12). 1011–1021. 14 indexed citations
13.
Matsuo, Yukiko, Kazu Shiomi, Masashi Mikubo, et al.. (2017). Molecular alterations in a new cell line (KU-Lu-MPPt3) established from a human lung adenocarcinoma with a micropapillary pattern. Journal of Cancer Research and Clinical Oncology. 144(1). 75–87. 4 indexed citations
14.
Mikubo, Masashi, et al.. (2017). Spontaneous non-traumatic mediastinal hematoma associated with oral anticoagulant therapy: A case report and literature review. International Journal of Surgery Case Reports. 39. 221–224. 7 indexed citations
15.
Takeda, Akira, et al.. (2013). Free Tensor Fascia Lata Flap and Synthetic Mesh Reconstruction for Full-Thickness Chest Wall Defect. Case Reports in Medicine. 2013. 1–3. 4 indexed citations
16.
Takeuchi, Kengo, Young Lim Choi, Yuki Togashi, et al.. (2009). KIF5B-ALK, a Novel Fusion Oncokinase Identified by an Immunohistochemistry-based Diagnostic System for ALK-positive Lung Cancer. Clinical Cancer Research. 15(9). 3143–3149. 557 indexed citations breakdown →
17.
Takeuchi, Kengo, Young Lim Choi, Manabu Soda, et al.. (2008). Multiplex Reverse Transcription-PCR Screening for EML4-ALK Fusion Transcripts. Clinical Cancer Research. 14(20). 6618–6624. 397 indexed citations
18.
Hiramatsu, Miyako, Hironori Ninomiya, Kentaro Inamura, et al.. (2007). EGFR signal pathways selectively activated in lung adenocarcinoma.. Cancer Research. 67. 5038–5038. 1 indexed citations
19.
Hiramatsu, Miyako, Takuya Inagaki, Yoshio Matsui, et al.. (2007). Appropriate Follow-up Interval of Thin Section CT Scan for Evaluating Pure Ground Glass Opacities of 10 mm or Less in the Lung Field. Haigan. 47(1). 27–35. 1 indexed citations
20.
Ishikawa, Yuichi, et al.. (2004). Micropapillary clusters in early-stage lung adenocarcinomas. Cancer. 102(2). 81–86. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026